Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2023

Accounting Policies [Abstract]

Schedule of Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

(in thousands)	September 30, 2023		December 31, 2022
Accounts payable	$	5,550	$	4,637
Accrued non-clinical liabilities	21,006		22,535
Accrued clinical liabilities	5,425		5,400
Total accounts payable and accrued liabilities	$	31,981	$	32,572

Schedule of Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share

Common stock equivalent securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows (in common stock equivalent shares; in thousands):

	September 30,
	2023	2022
Common stock options	12,526	9,093
Restricted stock units	701	—
Performance stock units	750	—
Employee Stock Purchase Plan shares pending issuance	109	27
Total	14,086	9,120